Skip to content

Utah Medical Products UTMD Purchase Obligation

Purchase Obligation at other companies

Stereotaxis logo
StereotaxisSTXS
$1.05M0.0%
CorMedix logo
CorMedixCRMD
$30M

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity
Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:ContractualObligation.

The official record: Utah Medical Products’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's purchase obligation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's purchase obligation?
Utah Medical Products (UTMD) reported purchase obligation of $4.34M in Q4 2025.
How has Utah Medical Products's purchase obligation changed year-over-year?
Utah Medical Products's purchase obligation increased by 15.8% year-over-year, from $3.75M to $4.34M.
What is the long-term trend for Utah Medical Products's purchase obligation?
Over 5 years (2020 to 2025), Utah Medical Products's purchase obligation has grown at a 5.7% compound annual growth rate (CAGR), from $3.29M to $4.34M.
What does purchase obligation mean?
This metric quantifies the total contractual commitments to acquire goods or services from third-party vendors at specified future dates. It reflects the company's forward-looking operational requirements and supply chain dependencies. Monitoring this figure helps investors evaluate future cash flow requirements and the company's ability to manage long-term procurement liabilities.